Liver transplant Flashcards

1
Q

Liver transplant - PRIC MCP?

A

P: primary disease, decompensation, complications MELD score, indication, deceased/living/orthotopic vs. split,/ABO/CMV.

Type of operation: duct to duct vs. Roux-en-Y

Note - Liver are not HLA matched.

R: RF for complications - prolonged ischaemic time, early rejection, compliance, return to ETOH

I: any recent biopsy, imaging (US/CT/MRCP/ERCP/stenting - biliary strictures)

Complications:

  • Transplant: peri/post-op complications, acute/chronic rejection/graft failure, hepatic artery thrombosis, portal/hepatc vein stenosis/obstruction, biliary stricture
    • Disease:* recurrence
  • Drugs: Metabolic, Infection (CMV, PCP, Fungal), Malignancy, Bone, Rejection + Hirsuitism/gingival hypeplasia, poor wound healing

M: current ImmSx regime, previous regime, infection prophylaxis, any recent changes in regime/dose and why. Steroid history.

How are drug metabolic complications Mx?

C: current problem, hospital admissions, how often is te F/U? How is patient/family coping? How is work affected?

P: insight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the prognosis of Liver transplant (1-y)

A

75%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the indications for liver transplant? (4)

A

End-stage Liver disease who had life-threatening episode of decompensation or QOL had become unbearably reduced.

  1. Child-Pugh >6
  2. MELD >10
  3. Episode of Variceal bleeding, SBP or grade II encephalopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are contraindications of Liver transplant?

A

Think top down:

General: active infection (including HIV, biliary infection), or incurable/advanced malignancy, continuing ETOH consumption.

Head: Significan psychiatric issues, non-adherence history, lack of social support.

Chest: Severe Cardio-respiratory disease that cannot be corected and is a risk for surgery, intra-pulmonary shunting, severe porto-pulmonary HTN

Abdo: Cholangiocarcinoma, Anatomic abnormaliies (e.g. prior complex HPB surgery), Vessel problems (PVT, previous porto-caval shunt (TIPSS is ok))

Renal: severe renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are immediate (post-op) complications of liver transplant? (5)

A

Primary graft non-function/failure

Technical problems (bleeding, thrombosis [HA,HV,PV], bile leak)

Acute CELLULAR rejection

Sepsis

Renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are medium-long term complications of liver transplantation?

A

Specific to Liver

Biliary Stricture

Hepatic artery stenosis/thrombosis

General complicaitons of any transplant

Rejection (acute or chronic)

Recurrence of primary disease

Infection: CMV, PCP, fungal

Metabolic: DM, HTN, Lipid, OP, weight gain

Malignancy: PTLD, skin, solid

Renal failure

Medication specific: CNI (neuropathy, CsA - hirsuitism, GH), Pancreatitis (AZA), Sirolimus (BM suppression, Hepatic artery thrombosis, impaired wound healing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pre-transplant work-up for Liver transplantation?

A

Assess disease severity & complications

  • LFTs and synthetic function
  • Decompensation: HE, SBP, varices
  • Symptoms: pruritis++ severely affecting QOL
  • MELD >10
  • Milan criteria (if HCC)

Assess for Cardio-pulmonary fitness

  • Cardiac: ECG, TTE with bubble study [assess for shun ?HPS], dobutamine ECHO or MIBI
  • Resp: ABG, Spirometry, PFT, 6MWT

Assess for vascular anatomy and HCC

  • Triple phase CT for above
  • Rule out HCC mets - bone scan, CT chest, CTB

Fitness for post-transplant care

  • Infection risk: HIV, Hep B/C, CMV
  • Assess for malignancy
  • Psychosocial evaluation: support/carer, coping skills, substance use, motivation, insight.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is your regime of prophylaxis post transplant depending on CMV status?

A

R +ve/ D +ve

R –ve/ D +ve

R-ve/ D -ve

Oral valganciclovir daily for 3/12

Oral valganciclovir daily for 6/12

Monitoring only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How would you manage CMV disease?

A

Antiviral: IV Ganciclovir for 1-2 weeks followed by 3 months of PO Valganciclovir.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is the anti-fungal prophylaxis is indicated in liver transplant? (3)

A

Most common infection is Candida. Prophylaxis is with Fluconazole.

Patients with long-term ABx use before transplant

Acute Liver failure

Complicated surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the dose regime of Bactrim in PCP prophylaxis?

A

Double strength 1/2 tablet 3 times/week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Liver transplant examination? (5)

A

Clubbing & Hypertension

Stigmata of chronic prednisolone use: candida, echymoses, cushingoid

No features of decompensation: flap & ascites

No Jaundice & Graft tenderness to suggest possible rejection or biliary stricture.

There was no signs of cyclosporin associated CNS toxicity with unremarkable Neurological examine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are DDx of fever in Liver transplant patient? (5)

A

Biliary tract stricture/cholangitis

CNS infection (especially fungal)

Hepatitis

Viral infection (CMV, HSV, VZV)

Pneumonia and UTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the long-term complications of Liver transplant and how would you manage them? (general + specific to liver transplant)

A

Goals: mainain graft function, prevent rejection and complications of immunosuppression - namely, infection, OP, malignancy, metabolic side effects and opimisation of vascular risk factors.

Rejection & Renal impairment

  • Monitor: graft tenderness, CNI levels, LFTs and EUCs
  • Biopsy if evidence of graft dysfunction
  • If confirmed pulse of methylpred + increase background ImmSx

Infection (including PCP, CMV, fungal)

  • Monitor: CNI levels to ensure not over-immunosuppressed, inflamatory markers, FBC for leukopaenia/atypical lymphocytes (CMV), consider CXR, urine and CMV PCR depending on presentation.
  • Non-pharm: educate, hygiene, vaccinate, low index of suspicion for infection & promp antimicrobials
  • Pharm: Bactrim, consider Valganciclovir (if serodiscordant or recipient +ve) and anti-fungal prophylaxis

Metabolic

  • Monitor: weight, BP, fasting lipids, glucose & HBA1C
  • Non-pharm: educate on CV risk, promote healthy life-style - diet, exercise, smoking cessation, moderation of ETOH
  • Pharm: diabetes control, statins, manage obesity and HTN.

Osteoporosis

  • Monitor: 1-2 yearly DEXA, Calcium, vitamin D (25) - aim >75
  • Non-pharm: Calcium and Vit D replacement
  • Pharm: denosumab or bisphosphonate when T-score <-1.5

Malignancy

  • Monitor: Low index of suspicion for solid tumour
  • Refer to dermatologist for regular skin checks

Biliary stricture

  • Monioring: LFT for cholestasis, if so investigate with USS/MRCP/ERCP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the recurrence rate of Liver disease in transplant patients?

Overall

HCV

PSC

A

Almost all liver diseases recur with exception of metabolic diseases

HCV recurence is universial, wih mean time to recuren cirrhosis of 7yrs

PSC - 20%

17
Q

What is your approach in managing derranged LFTs with cholestasis in patients with Liver transplant?

A

DDx - general and specific

Specific: biliary strictures, CBD stones, hepatic artery stenosis/thrombosis, graft rejection, recurrence of primary disease.

General: cholecystitis, choledocholitiasis, hepatitis (drugs, infective, autoimmune, alcoholic, NASH)

Approach

  1. USS + Doppler of RUQ/Hepatic vasculature - but sensitivity only 50%
  2. Further imaging often required - cholangiograms - i.e. MRCP is often first step → ERCP (if duct-to-duct) or PTC (Roux-en-Y)
  3. Liver biopsy

Management of Biliary stricture

ERCP + plastic stenting (change every 3 months) or ballon dilatation

PTC if biloma not communicating with bile duct

Re-fashion anastomosis

Re-transplant (especially if diffuse strictures)